Peripheral Arterial Disease Trial, Recruiting (NCT06448390)

Peripheral Arterial Disease Trial, Recruiting NCT06448390 Sponsor: Norwegian University of Science and Technology Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06448390 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You experience calf pain when walking 300 metres or less on a treadmill
Your symptoms have been stable and consistent for at least 6 months
Your calf pain goes away within 5 minutes after you stop walking
Your ankle-brachial index (a blood pressure test comparing your ankle and arm) is 0.7 or lower at rest (confirm with trial site)
You have been taking statins (cholesterol-lowering medication) and antiplatelet drugs (such as aspirin) for at least 3 months
You are 18 years of age or older
You are willing to sign a consent form to take part

Who may not be able to join:

Your pain while walking occurs in the hips or anywhere other than the calves
Your pain continues for more than 5 minutes after you stop walking
Your arteries cannot be compressed during the ankle-brachial index test, or your result is lower than 0.4 (confirm with trial site)
You have been taking statins and antiplatelet drugs for less than 3 months
Your symptoms have been present for less than 6 months
You have diabetes with a blood sugar level above a certain threshold measured by an HbA1c blood test (confirm with trial site)
You have had a procedure to restore blood flow to your arteries within the last 6 months
Your calf pain only occurs after walking more than 300 metres on a treadmill
You have reduced movement or stiffness in your ankles
You are physically unable to walk on a treadmill for testing
You are under 18 years of age
You have certain other health conditions — such as severe obesity, chronic lung disease, heart disease, or inflammatory joint conditions — that would affect your ability to take part in an exercise-based study (confirm with trial site)
You are not willing to sign a consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06448390

Sponsor: Norwegian University of Science and Technology

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

More information: https://clinicaltrials.gov/study/NCT06448390

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You experience calf pain when walking 300 metres or less on a treadmill
Your symptoms have been stable and consistent for at least 6 months
Your calf pain goes away within 5 minutes after you stop walking
Your ankle-brachial index (a blood pressure test comparing your ankle and arm) is 0.7 or lower at rest (confirm with trial site)
You have been taking statins (cholesterol-lowering medication) and antiplatelet drugs (such as aspirin) for at least 3 months
You are 18 years of age or older
You are willing to sign a consent form to take part

Who may not be able to join:

Your pain while walking occurs in the hips or anywhere other than the calves
Your pain continues for more than 5 minutes after you stop walking
Your arteries cannot be compressed during the ankle-brachial index test, or your result is lower than 0.4 (confirm with trial site)
You have been taking statins and antiplatelet drugs for less than 3 months
Your symptoms have been present for less than 6 months
You have diabetes with a blood sugar level above a certain threshold measured by an HbA1c blood test (confirm with trial site)
You have had a procedure to restore blood flow to your arteries within the last 6 months
Your calf pain only occurs after walking more than 300 metres on a treadmill
You have reduced movement or stiffness in your ankles
You are physically unable to walk on a treadmill for testing
You are under 18 years of age
You have certain other health conditions — such as severe obesity, chronic lung disease, heart disease, or inflammatory joint conditions — that would affect your ability to take part in an exercise-based study (confirm with trial site)
You are not willing to sign a consent form

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Norwegian University of Science and Technology

Registry

ClinicalTrials.gov

Start date

1 January 2024

Est. completion

31 December 2025

Where this trial is recruiting

🇳🇴 Norway 🇸🇪 Sweden

Primary endpoints

walking distance; Quality of life

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov